Abstract: Polar nematic compounds, one example of which has the following structure: is a caged boron structure, where the sphere of the caged boron structure is C and each non-sphere vertex of the caged boron structure is B—H. R is H, an alkyl, a cycloalkyl, a bicycloalkyl, an alkenyl, a cycloalkenyl, a bicycloalkenyl, an alkynyl, an acyl, an aryl, an alkylaryl, a halogen, a cyano group, or an isothiocyanoto group, or R is a group that forms an ether, a ketone, an ester, a thioester, a sulfide, or a sulfone. X is COOR? or COSR?. R? is H, an alkyl, a cycloalkyl, a bicycloalkyl, an alkenyl, a cycloalkenyl, a bicycloalkenyl, an alkynyl, an aryl, a halogen, or a cyano group. The compounds may be used in liquid crystal displays (LCDs), and in television sets, laptop computers, computer monitors, hand-held communication devices, gaming devices, watches, cash registers, clocks, and calculators having liquid crystal displays.

Abstract: The invention provides an ultrasound imaging and medical instrument guiding apparatus, a system for acquiring and displaying ultrasound medical images and methods of using the apparatus and system in epidural anesthetic procedure. The apparatus comprises a hand-held ultrasound probe, configured to acquire a volumetric dataset representing a 3-D depiction of a volume; a mount to which the probe is mounted; and a medical instrument guide positionable relative to the ultrasound probe and configured to receive and guide a medical instrument along a propagation axis to a target in a body such that the target and the propagation axis intersect in the volume. The volumetric dataset acquired by the hand-held ultrasound probe comprises information about the medical instrument's position relative to the target in three dimensions and the medical instrument guide has a visible mark from which the depth of the medical instrument insertion along the propagation axis can be referenced.

Abstract: This invention relates to methods for optimizing a golf swing by measuring and providing feedback on a combination of various key parameters of a subject's movement to both generate more power and reduce injury.

Abstract: Prodrug formulations of bioactive polypeptides are provided wherein the bioactive polypeptide has been modified by the linkage of a dipeptide to the bioactive polypeptide through an ester linkage. The prodrugs disclosed herein in some embodiments have extended half lives of at least 1.5 hours (e.g., at least 10 hours), and more typically greater than 20 hours and less than 70 hours, and are converted to the active form at physiological conditions through a non-enzymatic reaction driven by chemical instability.

Abstract: An intermetallic compound having excellent mechanical properties at high temperatures is provided. An intermetallic compound of the present invention contains greater than 5 at % and not greater than 13 at % of Al, not less than 9.5 at % and less than 17.5 at % of V, not less than 0 at % and not greater than 3.5 at % of Ti, not less than 0 weight ppm and not greater than 1000 weight ppm of B, and the remaining portion consisting of Ni and inevitable impurities, and having a dual multi-phase microstructure comprising a primary L12 phase and an (L12+D022) eutectoid microstructure.

Abstract: A pulse tube cryocooler modulating phase via an inertance tube and an acoustic amplifier (A1, A2) provided in the pulse tube cryocooler are disclosed. The acoustic power amplifier (A1, A2) is made of a metal pulse tube (PT1, PT2) filled with regenerative materials, which are located at a distance of X from the hot end of the pulse tube. The length of the regenerative materials is L which meets the requirement of X?L>0. The acoustic power amplifier (A1, A2) can be used not only in a single-stage pulse tube cryocooler, but also in a multi-stage pulse tube cryocooler thermally coupled or gas coupled. The regenerative materials may be any cold storage materials applicable at low temperatures, such as stainless steel wire mesh, lead pellet, lead thread et al. The acoustic power amplifier (A1, A2) can increase the acoustic power at the hot end of the pulse tube (PT1, PT2), which is advantageous to the phase modulation of the inertance tube, thereby the properties of the pulse tube cryocooler can be enhanced.

Abstract: Disclosed is a tissue-derived biomaterial carrier device (1) comprising a carrier case 810), an arm (125) provided upright on an interior bottom wall surface of the carrier case (10), a mounting part (121), a swing mechanism (122), a temperature control box (20) provided detachably on an exterior wall surface of the carrier case (10), and a heater (201) provided in the temperature control box (20). The mounting part (121) receives the mounting of a housing vessel in which a tissue-derived biomaterial is housed (an opening part (121a)). The swing mechanism (122) swingably supports the mounting part (121) relative to the arm (125). With the temperature control box (20) mounted on the carrier case (10), the heater (201) in the temperature control box (20) receives the supply of electric power from a battery (203) and regulates the temperature within the carrier case (10).

Abstract: A portable EEG (electroencephalograph) instrument, especially for use in emergencies and brain assessments in physicians' offices, detects and amplifies brain waves and converts then into digital data for analysis by comparison with data from normal groups. In one embodiment, the EEG electrodes are in a headband which broadcasts the data, by radio or cellular phone, to a local receiver for re-transmission and/or analysis. In another embodiment, the subject is stimulated in two modes, i.e., aural and sensory, at two different frequencies to provide the subject's EPs (Evoked Potentials), assessing transmission through the brainstem and thalamus.

Abstract: The subject disclosure relates to solar energy collection and use in communications systems and to enhancements thereof. In an aspect, dual function antennas are disclosed that can simultaneously function as an antenna and as a solar energy collection system. In further aspects, disclosed embodiments can focus incident solar radiation to increase output voltage of conventional solar cells. Measured and simulated results demonstrate various aspects of the subject disclosure.

Abstract: A solar collector includes a substrate having a top surface and a bottom surface opposite to the upper surface, a sidewall, a transparent cover, and a heat-absorbing layer. The sidewall is arranged on the top surface of the substrate. The transparent cover is disposed on the sidewall opposite to the substrate to form a sealed chamber with the substrate together. The heat-absorbing layer is disposed on the upper surface of the substrate and includes a carbon nanotube film having a plurality of carbon nanotubes. The carbon nanotubes in the carbon nanotube film are entangled with each other.

Abstract: Prodrug formulations of insulin and insulin analogs are provided wherein the insulin peptide has been modified by an amide bond linkage of a dipeptide prodrug element. The prodrugs disclosed herein have extended half lives of at least 10 hours, and more typically greater than 2 hours, 20 hours and less than 70 hours, and are converted to the active form at physiological conditions through a non-enzymatic reaction driven by chemical instability.

Abstract: The present invention relates to 2,6,10-trimethyl-3,5,9-undecatrienyl-1-aldehyde represented by formula (3), and a method for preparing this intermediate. The process route of the present invention is simple, the starting materials are available easily, and the cost is low.

Abstract: A method and system of scheduling demands on a system having a plurality of resources are provided. The method includes the steps of, on receipt of a new demand for resources: determining the total resources required to complete said demand and a deadline for the completion of that demand; determining a plurality of alternative resource allocations which will allow completion of the demand before the deadline; for each of said alternative resource allocations, determining whether, based on allocations of resources to existing demands, said alternative resource allocation will result in a utilization of resources which is closer to an optimum utilization of said resources; and selecting, based on said determination, one of said alternative resource allocations to complete said demand so as to optimise utilization of resources of the system.

Abstract: A method for producing methanol from a methane source such as methane from natural (shale) gas by first reacting one equivalent of methane with oxygen from the air to result in complete combustion to produce carbon dioxide and water in a molar ratio of 1:2; then conducting a bi-reforming process with a mixture of methane:carbon dioxide:water having a ratio of 3:1:2 to produce metgas, a mixture of hydrogen and carbon monoxide having a molar ratio of 2:1 to 2.1:1; and finally converting metgas exclusively to methanol. The thus produced methanol can be dehydrated to form dimethyl ether, with water produced being recycled back to the bi-reforming process, if necessary.

Abstract: Described herein are biomarkers, such as protein biomarkers, which are diagnostic of and predictive for complications that result from an in utero encounter, such as an infection by the fetus, that can lead to premature birth (PTB). The biomarkers can be used to identify fetuses and newborns at risk for complications of PTB, such as (Early Onset Neonatal Sepsis) EONS, intra-ventricular hemorrhage (IVH) and other poor outcomes.

Abstract: A method of treating gamma oncogenic herpesviruses, in vivo, through use of Delta-9 Tetrahydrocannabinol (THC). THC inhibits KSHV and EBV reactivation as well as inhibiting lytic replication of MHV 68 and HVS in vitro. Specifically, THC inhibits immediate early gene ORF 50 promoter activity.

Abstract: The present invention provides a film composition effective for correcting irregularities on the skin surface, which has stretchability and flexibility as a result of crosslinkable protein microparticles in the film composition being crosslinked by transglutaminase, as well as superior air permeability and moisture evaporation properties as a result of forming a film with the crosslinkable protein microparticles.

Abstract: The present invention provides methods for reducing and/or evaluating the immunogenic potential of a therapeutic protein preparation. The present invention further provides pharmaceutical compositions of therapeutic proteins and methods of treatment with the same, the compositions having low immunogenic potential and/or improved efficacy. The invention achieves these goals by evaluating therapeutic protein preparations for subvisible protein particulates, which can contribute significantly to the overall immunogenic potential of the protein preparation. Further, by maintaining the content of such subvisible protein particulates to below an immunogenic threshold level, the resulting pharmaceutical composition is less likely to result in a loss of tolerance (e.g., upon repeated administration), thereby improving both the safety and efficacy profile of the therapeutic.

Abstract: A motion recognizing apparatus and method are provided. According to an aspect, a motion recognizing apparatus may include: an optical sensor configured to sense at least a portion of a subject where a motion occurs and to output one or more events in response thereto; a motion tracing unit configured to trace a motion locus of the portion where the motion occurs based on the one or more outputted events; and a motion pattern determining unit configured to determine a motion pattern of the portion where the motion occurs based on the traced motion locus.

Abstract: An electret loudspeaker device including a diaphragm, a first perforated electrode and a first spacer is provided. The diaphragm has an electret layer and an electrode layer. The first perforated electrode is stacked on a side of the diaphragm near the electret layer, and has multiple holes. The first spacer is stacked between the diaphragm and the first perforated electrode, and includes a first distribution area and plural second distribution areas. The first distribution area has first openings penetrating through the first spacer, and each first opening has a first opening space volume between the diaphragm and the first perforated electrode. Each second distribution area has second openings penetrating through the first spacer, and each second opening has a second opening space volume between the diaphragm and the first perforated electrode. A difference between the first and the second opening space volumes is greater than 10%.